CDCA3 and non-small cell lung carcinoma: We also demonstrate that while CDCA3 protein levels are regulated by the anaphase-promoting complex/cyclosome (APC/C) in NSCLC, pharmacological strategies to block this protein–protein interaction enhance sensitivity to platinum agents.